Navigation Links
UTHealth faculty members elected to prestigious scientific association
Date:12/13/2013

Two professors at The University of Texas Health Science Center at Houston (UTHealth) Barry Davis, M.D., Ph.D., and Kevin Morano, Ph.D. have been elected fellows into the American Association for the Advancement of Science (AAAS), the world's largest general scientific society and publisher of the journal Science.

Davis is recognized for his leadership to advance public health and his contributions to clinical trials especially in high blood pressure and Morano for his investigations into mechanisms underlying Alzheimer's disease and other conditions.

Davis and Morano were among 388 AAAS members awarded this honor in 2013 and will be recognized on Feb. 15 at the 2014 AAAS Annual Meeting in Chicago. Elected by their AAAS peers, fellows are chosen based on their scientifically or socially distinguished efforts to advance science or its applications.

"UTHealth is proud of this national recognition for two of our exceptional scientists. This is a well-deserved honor for Drs. Morano and Davis and speaks to the caliber of science at UTHealth," said UTHealth President Giuseppe Colasurdo, M.D.

Davis, a biostatistician, led a landmark study of blood pressure medications, which found that diuretics or water pills matched or outperformed higher priced medications. More than 42,000 people participated in the study called the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

ALLHAT findings were confirmed in follow-up studies demonstrating that diuretics remain unsurpassed when it comes to reducing high blood pressure and preventing major complications.

Davis is the holder of the Guy S. Parcel Chair in Public Health and director of the Coordinating Center for Clinical Trials at The University of Texas School of Public Health, part of UTHealth. He received his medical degree at University of California, San Diego and his doctorate degree at Brown University.

"I am grateful to be recognized for our accomplishments in clinical trials. It has been an honor and a privilege to work with so many wonderful people at the Coordinating Center and across the country to help improve the public's health," Davis said.

Morano's research focuses on how proteins achieve their properly folded structure that allows them to perform their functions and maintain cells in a healthy state.

Much like the intricate and precise way paper is folded in origami, proteins have to be accurately folded inside cells. Many neurodegenerative disorders including Parkinson's disease and Lou Gehrig's disease are caused when proteins are not folded correctly and Morano's work contributes to understanding how this may be corrected.

"It's a great honor to be recognized for the work my students and I have been doing here at UTHealth Medical School. Most importantly, it's recognition from fellow scientists in our field, which is pretty cool," Morano said.

Morano, a microbiologist, is the director of the New Investigator Development Program at UTHealth Medical School and faculty president at The University of Texas Graduate School of Biomedical Sciences at Houston. He received his doctorate degree at the University of California, Davis, and completed his postdoctoral fellowship at the University of Michigan.

Other UTHealth faculty members elected as AAAS fellows include: L. Maximilian Buja, M.D.; John H. "Jack" Byrne, Ph.D.; John DeMoss, Ph.D.; Carmen Dessauer, Ph.D.; Bruce C. Kone, M.D.; Frank G. Moody, M.D.; Kathleen Gibson, Ph.D.; Irma Gigli, M.D.; Sam Kaplan, Ph.D.; James Willerson, M.D.; and Jerry Wolinsky, M.D.


'/>"/>

Contact: Robert Cahill
Robert.Cahill@uth.tmc.edu
713-500-3030
University of Texas Health Science Center at Houston
Source:Eurekalert  

Related biology news :

1. UTHealth, Swedish researchers uncover mystery in blot clotting disorder
2. UTHealth study addresses barriers to physical activity counseling
3. Wyss Institute at Harvard University announces election of 2 faculty to Natl Academy of Inventors
4. 5 Penn faculty earn distinction as AAAS Fellows
5. Wyss Institute core faculty member elected to the Institute of Medicine of the National Academies
6. Outside mentoring support for science faculty at minority-serving institutions pays off
7. 2 UCLA faculty elected to National Academy of Sciences
8. 3 NYU faculty elected to National Academy of Sciences
9. Winners of the 2012 F1000Prime Faculty Member of the Year Awards
10. UMass Medical School faculty elected to the American Association for the Advancement of Science
11. U of M faculty find antimicrobials altering intestinal bacteria composition in swine
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UTHealth faculty members elected to prestigious scientific association
(Date:2/2/2016)... Feb. 2, 2016 Checkpoint Inhibitors for ... Market Are you interested in the future ... for checkpoint inhibitors. Visiongain,s report gives those predictions ... and national level. Avoid falling behind in ... opportunities and revenues those emerging cancer therapies can ...
(Date:2/1/2016)... -- Today, the first day of American Heart Month, the ... first of its kind workplace health solution that leverages ... first application of Watson to ... Welltok will create a new offering that combines AHA,s ... on Welltok,s health optimization platform. The effort is intended ...
(Date:1/25/2016)... , Jan. 25, 2016  Glencoe Software, the ... pharma and publication industries, will provide the data management ... Centre (NPSC). ... Phenotypic analysis measures ... whole organisms, allowing comparisons between states such as health ...
Breaking Biology News(10 mins):
(Date:2/10/2016)... , ... February 10, 2016 , ... ... the International Society of Pharmaceutical Engineering (ISPE) Rocky Mountain Chapter 21st Annual Vendor ... expecting to fill more than 100 tables for its annual event, which will ...
(Date:2/10/2016)... ... February 10, 2016 , ... PatientCrossroads announces ... the secure online PatientCrossroads platform, has exceeded both its one-year and overall recruitment ... PROMPT study, which seeks to advance understanding of the hereditary risks for certain ...
(Date:2/10/2016)... ... February 10, 2016 , ... Cenna Bioscience Inc., an ... treatment of Alzheimer’s disease, announced today it has been selected to present at the ... Breakers in Palm Beach, Florida. The purpose of the Forum is to help ...
(Date:2/9/2016)... 9, 2016  Regenicin, Inc. (OTC Bulletin Board: ... the development and commercialization of regenerative cell therapies ... organs, recently reported the Company,s operating results for ... 2016. Lonza America , Inc. (the ... year in the process of consummating an agreement ...
Breaking Biology Technology: